Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02768896
Other study ID # 0182-16RMB
Secondary ID
Status Not yet recruiting
Phase N/A
First received April 4, 2016
Last updated June 6, 2016
Start date June 2016
Est. completion date February 2018

Study information

Verified date June 2016
Source Rambam Health Care Campus
Contact Ilana Schlesinger, MD
Phone 972502062529
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

Voltage fluctuation as a result of brain activity will be recorded into the computer using an EEG device.


Description:

Patients with Parkinson's disease may have gait disturbances including freezing of gait. Visual and auditory stimuli may improve gait. Investigators will analyze brain wave during walking while giving the subject different stimuli.

The voltage fluctuation (in hundreds of microvolts) will be recorded using the EEG cap and amplifier into a computer.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date February 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

• Patients with Parkinson's disease that are ambulatory and can sign a written informed consent

Exclusion Criteria:

- Patients with Parkinson's disease who are not ambulatory

- Patients with dementia

- Patients that are blind

- Patients that have severe hearing impairment

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Behavioral:
Baseline
Patients will walk naturally with EEG measuring brain waves
visual stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses
Auditory stimuli
Patients will walk naturally with EEG measuring brain waves while hearing an auditory stimuli
Visual and auditory stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses and hearing an auditory stimuli simultaneously

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Rambam Health Care Campus Technion, Israel Institute of Technology

Outcome

Type Measure Description Time frame Safety issue
Primary Voltage fluctuation resulting from brain activity after visual stimuli Change in brain wave activity after visual stimuli as compared with baseline measured in tens of micro-volts per second. One hour No
Primary Voltage fluctuation resulting from brain activity after auditory stimuli Change in brain wave activity after auditory stimuli as compared with baseline measured in tens of micro-volts per second. One hour No
Primary Voltage fluctuation resulting from brain activity after visual and auditory stimuli Change in brain wave activity after visual and auditory stimuli as compared with baseline measured in tens of micro-volts per second. One hour No
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Completed NCT02874274 - Vaccination Uptake (VAX) in PD N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2